The phase 1/2 randomized trial compared results from the measles and rubella vaccine delivered by a microarray patch, a small sticking plaster-like device with an array of microscopic projections that painlessly penetrate the skin and deliver the vaccine, or by conventional injection with a needle and syringe.
Measles and rubella vaccine delivered via microarray patch shows promising results
- Post author:
- Post published:April 29, 2024
- Post category:uncategorized